Clinical trial
A Phase I Study of CX5461
NCT02719977 is registered in ClinicalTrials.gov with Canadian Cancer Trials Group as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase I Study of CX5461
- Lead sponsor
- Canadian Cancer Trials Group
- Phase
- Phase 1
- Overall status
- Completed
- Start date
- June 13, 2016
- Completion date
- January 18, 2023
- Enrollment
- 41 (actual)
- Sites
- 3
Conditions
As the registry lists them; a condition with its own page is linked.
cancer